Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, and it can shapeshift in unpredictable ways to evade treatment.

A Peninsula biotech company focusing on a deadly lung-scarring disease lost more than half its stock value Monday after ...

Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...

Children diagnosed with interstitial lung disease often survive into adulthood, when they are likely to need care for related impairments.

Blinded baseline demographics and disease characteristics for ongoing Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline ...

From 1990 to 2019, global lung cancer mortality rates related to tobacco have gone down, whereas rates related to ambient ...

aDepartment of Clinical Biochemistry, Zealand University Hospital, Lykkebækvej 1, 4600 Køge, Denmark bDepartment of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200 ...

The Standard's journalism is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission. Katie Price has given fans a health update after getting ...

To diagnose chronic obstructive pulmonary disease (COPD), doctors typically use spirometry to measure your lung function. They usually also perform other tests to monitor the damage to your lungs.

COPD is a progressive, irreversible inflammatory disease of the lungs that makes it difficult to breathe. Cigarette smoking is the most common cause of COPD. Common symptoms include a persistent cough ...

Furthermore, the patchy nature of the lung pathology is influenced by specific disease-related alterations ... may be affected even more than the parenchyma. Emphysema is patchy at the same ...